Tenaya Therapeutics Inc(TNYA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TNYA Tenaya Therapeutics Inc

Market Closed 07-31 16:00:00 EDT

0.7403

-0.0097

-1.29%

盘后0.7439

+0.0036+0.48%

19:51 EDT

High0.7650	Low0.7200	Vol1.62M
Open0.7500	D1 Closing0.7500	Amplitude6.00%
Mkt Cap160.28M	Tradable Cap152.38M	Total Shares216.51M
T/O1.20M	T/O Rate0.79%	Tradable Shares205.84M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TNYA","market":"US","secType":"STK","nameCN":"Tenaya Therapeutics Inc","latestPrice":0.7403,"timestamp":1785528000000,"preClose":0.75,"halted":0,"volume":1624618,"hourTrading":{"tag":"盘后","latestPrice":0.743876,"preClose":0.7403,"latestTime":"19:51 EDT","volume":19044,"amount":14300.440556,"timestamp":1785541918179,"change":0.003576,"changeRate":0.00483,"amplitude":0.033635},"delay":0,"changeRate":-0.012933333333333389,"floatShares":205841252,"shares":216505900,"eps":-0.461845,"marketStatus":"Market Closed","change":-0.0097,"latestTime":"07-31 16:00:00 EDT","open":0.75,"high":0.765,"low":0.72,"amount":1202581.62434032,"amplitude":0.06,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.461845,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785744000000},"marketStatusCode":7,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.75,"preHourTrading":{"tag":"盘前","latestPrice":0.753,"preClose":0.75,"latestTime":"09:28 EDT","volume":5668,"amount":4241.4131448,"timestamp":1785504503836,"change":0.003,"changeRate":0.004,"amplitude":0.069867},"postHourTrading":{"tag":"盘后","latestPrice":0.743876,"preClose":0.7403,"latestTime":"19:51 EDT","volume":19044,"amount":14300.440556,"timestamp":1785541918179,"change":0.003576,"changeRate":0.00483,"amplitude":0.033635},"volumeRatio":0.9965445816079944,"impliedVol":1.0157,"impliedVolPercentile":0.239},"requestUrl":"/m/hq/s/TNYA/wiki","defaultTab":"wiki","newsList":[{"id":"2655890512","title":"Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bausch + Lomb Corporation (BLCO) and Curis (CRIS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655890512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655890512?lang=en_us&edition=fundamental","pubTime":"2026-07-30 01:40","pubTimestamp":1785346810,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Tenaya Therapeutics (TNYA), Bausch + Lomb Corporat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tenaya-therapeutics-tnya-bausch-lomb-corporation-blco-and-curis-cris-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tenaya-therapeutics-tnya-bausch-lomb-corporation-blco-and-curis-cris-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","HCSG","BK4139","BK4581","BK4198","BK4585","BK4588","TNYA","CRIS","XLV","LU0128526141.USD","XBI","BK4539","BK4137","BLCO","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651477480","title":"Tenaya Therapeutics CFO Eric J. Hyllengren Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2651477480","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651477480?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:04","pubTimestamp":1784077460,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics CFO Eric J. Hyllengren files initial beneficial ownership statementTenaya Therapeutics CFO Eric J. Hyllengren filed an initial Form 3 insider ownership statement dated July 13, 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL6NckxK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480483","title":"Tenaya Therapeutics Grants CFO Stock Options for 1.65 Million Shares at $0.84 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480483","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651480483?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:00","pubTimestamp":1784077257,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics grants CFO stock options for 1.65 million shares at $0.84 eachTenaya Therapeutics granted stock options for 1,650,000 shares to newly appointed CFO Eric Hyllengren.Two new non-exec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDLc75JjS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480488","title":"Tenaya Therapeutics Grants CFO Hyllengren Options to Buy 1.65 Million Shares at $0.84 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480488","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651480488?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:00","pubTimestamp":1784077213,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics grants CFO Hyllengren options to buy 1.65 million shares at $0.84 eachTenaya Therapeutics granted stock options covering 1,837,200 shares to newly hired employees, including CFO Er","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL36MDlh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4112","BK4588","IE00BKPKM429.USD","BK4539","SG9999014039.USD","LU2095319765.USD","BK4139","BCDF","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","NDAQ","TNYA","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","BK4585","SG9999014005.SGD","LU0314104364.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480154","title":"Tenaya Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651480154?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:00","pubTimestamp":1784077200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA9BGNMH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651343844","title":"Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651343844","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651343844?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:00","pubTimestamp":1784077200,"startTime":"0","endTime":"0","summary":"VP, Corporate Communications and Investor Relations","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/15/3327426/0/en/Tenaya-Therapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","NVIW.SI","MNQmain","QQQE",".IXIC","TNYA","FTEC","HCM","QQQ","QQQM","TQQQ","NDX","TECS","ONEQ","BK4588","PSQ","QQQA","JEPQ","BK4539","TQQY","BK4531","SQQQ","NQmain","IYW","QQQJ","QYLG","BK4139","QQQY","QID","GPIQ","QLD","QDTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649265336","title":"Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Tenaya Therapeutics (TNYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649265336","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649265336?lang=en_us&edition=fundamental","pubTime":"2026-07-06 19:20","pubTimestamp":1783336818,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Perspective Therapeutics (CATX) and Tenaya Therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LABU","LU0029874061.USD","XBI","BK4137","HCSG","TNYA","CATX","XLV","BK4585","BK4581","BK4139","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648636120","title":"Tenaya Therapeutics Ends Manufacturing Center Lease, Shifts Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2648636120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648636120?lang=en_us&edition=fundamental","pubTime":"2026-07-03 05:36","pubTimestamp":1783028202,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Tenaya Therapeutics ( ($TNYA) ). On June 29, 2026, Tenaya Therapeutics, Inc. agreed to terminate its lease for ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-ends-manufacturing-center-lease-shifts-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-ends-manufacturing-center-lease-shifts-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648635959","title":"Tenaya Therapeutics to Terminate Union City Manufacturing Lease, Forfeits $1.75 Million Deposit","url":"https://stock-news.laohu8.com/highlight/detail?id=2648635959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648635959?lang=en_us&edition=fundamental","pubTime":"2026-07-03 05:02","pubTimestamp":1783026120,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics to terminate Union City manufacturing lease, forfeits $1.75 million depositTenaya Therapeutics entered a lease termination agreement for its Union City, California genetic medicine","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL8cD2dh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647372749","title":"Tenaya Therapeutics Appoints New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2647372749","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647372749?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:30","pubTimestamp":1782739846,"startTime":"0","endTime":"0","summary":"An update from Tenaya Therapeutics ( ($TNYA) ) is now available. Tenaya Therapeutics, a clinical-stage biotech developing genetic medicines for hea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tenaya-therapeutics-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647374088","title":"Tenaya Therapeutics Names Eric Hyllengren CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2647374088","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647374088?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:09","pubTimestamp":1782738553,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics (TNYA) said Monday that it has appointed Eric Hyllengren as Chief Financial Officer, starting July 13.Tenaya said Hyllengren was most recently CFO of Zura Bio (ZURA).","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","TNYA","ZURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647741083","title":"Tenaya Therapeutics appoints Eric Hyllengren as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2647741083","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647741083?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:01","pubTimestamp":1782738096,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics (TNYA) announced the appointment of Eric Hyllengren as CFO, effective July 13. In this role, he will oversee financial strategy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-appoints-eric-hyllengren-as-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-appoints-eric-hyllengren-as-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647371946","title":"Press Release: Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2647371946","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647371946?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:30","pubTimestamp":1782736200,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentia","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4539","HCM","BK4585","BK4531","BK4139","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641016464","title":"Tenaya Therapeutics posts Jefferies healthcare conference deck on heart disease gene therapy pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2641016464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641016464?lang=en_us&edition=fundamental","pubTime":"2026-06-05 03:23","pubTimestamp":1780601035,"startTime":"0","endTime":"0","summary":"Tenaya highlighted 2026 catalysts to advance TN-201 and TN-401 toward pivotal-study planning, with regulatory endpoint and design updates expected in 2H 2026.TN-201 MyPEAK-1 interim data showed improvement across biomarkers, hypertrophy measures, symptom scores, and functional capacity, with durability out to 2 years in Cohort 1.All evaluable TN-201 patients achieved LVMI reductions; Cohort 2 showed declines as early as week 26, including -21% and -25% in two patients.TN-201 safety profile remained consistent, with mostly mild, transient, reversible adverse events; the most common were asymptomatic liver enzyme elevations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenaya Therapeutics Inc. published the original content used to gen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL977zlw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640184246","title":"Tenaya Therapeutics management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2640184246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640184246?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:45","pubTimestamp":1780519527,"startTime":"0","endTime":"0","summary":"Meeting to be held in New York on June 4 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tenaya-therapeutics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640186238","title":"Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Tenaya Therapeutics (TNYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640186238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640186238?lang=en_us&edition=fundamental","pubTime":"2026-06-04 02:20","pubTimestamp":1780510843,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cabaletta Bio (CABA) and Tenaya Therapeutics (TNYA) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cabaletta-bio-caba-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cabaletta-bio-caba-and-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","TNYA","BK4585","XBI","BK4139","CABA","LABU","XLV","BK4539","BK4581","LU0128526141.USD","HCSG","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640185440","title":"Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Tenaya Therapeutics (TNYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640185440","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640185440?lang=en_us&edition=fundamental","pubTime":"2026-06-04 01:00","pubTimestamp":1780506041,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ligand Pharma (LGND) and Tenaya Therapeutics (TNYA) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-ligand-pharma-lgnd-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-ligand-pharma-lgnd-tenaya-therapeutics-tnya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TNYA","BK4539","BK4139","IE0009354923.USD","LU1559883803.SGD","BK4007","LU0566484027.USD","LGND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906987","title":"Tenaya Therapeutics - Cohort 1 Benefits Sustained up to Two Years; Cohort 2 Shows Earlier Improvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906987?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906933","title":"Tenaya Therapeutics - All Evaluable Patients Show Improvements in Mybpc3-Associated HCM After Tn-201 Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906933?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906520","title":"Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment of Mybpc3-Associated HCM With Tn-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640906520?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:00","pubTimestamp":1780484402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA5X0PYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tenayatherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0448},{"period":"1month","weight":-0.0075},{"period":"3month","weight":0.0489},{"period":"6month","weight":-0.0444},{"period":"1year","weight":0.0951},{"period":"ytd","weight":0.0405}],"compareEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0366},{"period":"6month","weight":0.0796},{"period":"1year","weight":0.1819},{"period":"ytd","weight":0.0955}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular regeneration, and gene addition. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy which is in phase 1 clinical trial; TN-301, a small molecule for heart failure with preserved ejection fraction which is in phase 1 clinical trial; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy which is in preclinical stage. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.091688},{"month":2,"riseRate":0.2,"avgChangeRate":-0.006231},{"month":3,"riseRate":0.4,"avgChangeRate":-0.077091},{"month":4,"riseRate":0.2,"avgChangeRate":0.069395},{"month":5,"riseRate":0.4,"avgChangeRate":0.046898},{"month":6,"riseRate":0.2,"avgChangeRate":-0.085773},{"month":7,"riseRate":0.6,"avgChangeRate":-0.018309},{"month":8,"riseRate":0.4,"avgChangeRate":0.09529},{"month":9,"riseRate":0.4,"avgChangeRate":-0.101393},{"month":10,"riseRate":0.2,"avgChangeRate":-0.046678},{"month":11,"riseRate":0.4,"avgChangeRate":0.123533},{"month":12,"riseRate":0.2,"avgChangeRate":-0.128991}],"exchange":"NASDAQ","name":"Tenaya Therapeutics Inc","nameEN":"Tenaya Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tenaya Therapeutics Inc(TNYA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tenaya Therapeutics Inc(TNYA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tenaya Therapeutics Inc,TNYA,Tenaya Therapeutics Inc股票,Tenaya Therapeutics Inc股票老虎,Tenaya Therapeutics Inc股票老虎国际,Tenaya Therapeutics Inc行情,Tenaya Therapeutics Inc股票行情,Tenaya Therapeutics Inc股价,Tenaya Therapeutics Inc股市,Tenaya Therapeutics Inc股票价格,Tenaya Therapeutics Inc股票交易,Tenaya Therapeutics Inc股票购买,Tenaya Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tenaya Therapeutics Inc(TNYA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tenaya Therapeutics Inc(TNYA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}